5AM Venture Management

5AM Venture Management as of June 30, 2023

Portfolio Holdings for 5AM Venture Management

5AM Venture Management holds 24 positions in its portfolio as reported in the June 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Enliven Therapeutics (ELVN) 29.5 $118M 5.8M 20.41
Entrada Therapeutics (TRDA) 16.6 $67M 4.4M 15.14
Disc Medicine (IRON) 5.4 $22M 488k 44.40
Rallybio Corp (RLYB) 5.1 $21M 3.6M 5.66
Vor Biopharma (VOR) 4.9 $20M 6.4M 3.09
Moonlake Immunotherapeutics Class A Ord (MLTX) 4.5 $18M 358k 51.00
Crinetics Pharmaceuticals In (CRNX) 3.9 $16M 862k 18.02
Zentalis Pharmaceuticals (ZNTL) 3.4 $14M 490k 28.21
Scpharmaceuticals (SCPH) 3.0 $12M 1.2M 10.19
Celldex Therapeutics Com New (CLDX) 2.6 $11M 310k 33.93
Viking Therapeutics (VKTX) 2.4 $9.5M 585k 16.21
Cogent Biosciences (COGT) 2.3 $9.4M 790k 11.84
Pharvaris N V (PHVS) 2.2 $8.9M 588k 15.14
Arvinas Ord (ARVN) 2.0 $7.9M 320k 24.82
Avidity Biosciences Ord (RNA) 1.8 $7.4M 666k 11.09
Anaptysbio Inc Common (ANAB) 1.8 $7.3M 358k 20.34
Mirati Therapeutics 1.7 $7.0M 193k 36.13
Miragen Therapeutics (VRDN) 1.7 $6.7M 280k 23.79
Spruce Biosciences (SPRB) 1.3 $5.1M 2.4M 2.15
Mersana Therapeutics (MRSN) 1.1 $4.3M 1.3M 3.29
Homology Medicines 1.0 $4.0M 4.5M 0.89
Impel Neuropharma (IMPLQ) 0.9 $3.7M 2.9M 1.27
Gh Research Ordinary Shares (GHRS) 0.4 $1.8M 152k 11.87
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) 0.3 $1.3M 1.1M 1.13